OrisDX
About:
OrisDX provides a saliva-based molecular detection method to check oral cavity pre-malignancies and cancers.
Website: https://www.orisdx.com
Top Investors: Polsky Center for Entrepreneurship and Innovation, SMILE Health, George Shultz Innovation Fund
Description:
OrisDX provides a saliva-based molecular detection method to check oral cavity pre-malignancies and cancers.
Total Funding Amount:
$865000
Headquarters Location:
Chicago, Illinois, United States
Founded Date:
2021-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2022-07-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai